Curis Lifesciences SME GMP - Live Grey Market Premium

Alloted
Curis Lifesciences SME

Curis Lifesciences Limited is a pharmaceutical manufacturing company specializing in a wide range of dosage forms, including tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates through three main business models: Loan License Manufacturing (job worker for domestic clients), Contract Manufacturing (supplying finished products to domestic suppliers and merchant exporters to countries like Kenya, Nigeria, and the UK), and Direct Export / Own Brand Manufacturing (exporting products under its own brands to regions like Yemen and Kenya). The company's manufacturing facility in Sanand, Gujarat, has significant annual capacities across its various product forms and is utilizing IPO proceeds for major capacity upgrades, construction of a storage facility, and product registrations in new countries.

Issue Price
128
Current GMP
9
GMP %
+7.03
Est. Listing Price
137
Advertisement

IPO Details

Price Range
₹120.0 - ₹128.0
Issue Size
₹26.14 Cr
Lot Size
1000 shares
IPO Type
NSE SME
Open Date
7 Nov 2025
Close Date
11 Nov 2025
Allotment Date
12 Nov 2025
Listing Date
14 Nov 2025

GMP Timeline

DateIPO PriceGMPEst. Price% Change
12 Nov 2025Live
128
6
134
+4.69
11 Nov 2025
128
6
134
+4.69
10 Nov 2025
128
8
136
+6.25
9 Nov 2025
128
8
136
+6.25
8 Nov 2025
128
8
136
+6.25
7 Nov 2025
128
7
135
+5.47
6 Nov 2025
128
7
135
+5.47
5 Nov 2025
128
6
134
+4.69
4 Nov 2025
128
0
128
0.00
3 Nov 2025
128
0
128
0.00
1 Nov 2025
128
0
128
0.00
31 Oct 2025
128
0
128
0.00
Advertisement

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.